About
NeuroLenTech develops precision medicine therapeutics for neurodevelopmental disorders by using proprietary patient-derived neuronal cell models to accelerate drug discovery for conditions such as epilepsy, severe autism, and intellectual disability.
Explore NeuroLenTech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.